Clinical Trial Results:
            A 52-week extension to a multicenter, randomized, double-blind, active controlled study to compare the effect of 52 weeks treatment with LAF237 50 mg bid to metformin up to 1000 mg bid in drug naïve patients with type 2 diabetes
    
|     Summary | |
|     EudraCT number | 2004-002136-25 | 
|     Trial protocol | GB ES | 
|     Global completion date | 
                                    02 Aug 2006
                             | 
|     Paediatric regulatory details | |
|     Is the trial part of an agreed EMA paediatric investigation plan? | 
                                        No
                                 | 
|     Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? | 
                                        No
                                 | 
|     Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? | 
                                        No
                                 | 
|     Results information | |
|     Results version number | v1(current) | 
|     This version publication date | 
                                    12 Oct 2016
                             | 
|     First version publication date | 
                                    12 Oct 2016
                             | 
|     Other versions | |
|     Summary report(s) | CLAF237A2309E1_NovCTR | 
            Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to            Commission Guideline 2012/C 302/03
            for further information.    
 
				
